Höglund Medical Oy is a limited company based in Espoo, registered in 2018. In the financial year ending 30.11.2025, revenue was 340 t€ and operating profit 153 t€; equity ratio 97.5 %. Its taxable income in 2024 was 181 t€ and its income taxes 36 t€.
Revenue 2025340 t€+7 % on the previous year
Operating profit153 t€44,9 % of revenue
Net profit74 t€EBITDA 151 t€
Equity ratio97,5 %quick ratio 13,60
Taxable income 2024181 t€
top quarter of its industry
Income taxes 202436 t€93 t€ in 2020–2024
In business8 yrsregistered 23.2.2018
Espoo: 106 new companies in 30 days
- Ilovite OyOhjelmistojen suunnittelu ja valmistus
- Kahvila Tuisku OyKahvilat ja muu alkoholittomien juomien tarjoilu
- Mizero OyErikoistumaton agentuuritoiminta
Try for free
Get your area's new companies by email every morning. 14 days, no card needed.
Financials
RevenueOperating profitNet profit
| Key figures | 30.11.2025 | 30.11.2024 |
|---|---|---|
| Revenue | 340 t€ | 318 t€ |
| Revenue change | 7,0 % | – |
| EBITDA | 151 t€ | 172 t€ |
| EBITDA % | 44,4 % | 54,2 % |
| Operating profit | 153 t€ | 174 t€ |
| Operating margin | 44,9 % | 54,9 % |
| Net profit | 74 t€ | 145 t€ |
| Personnel costs | -84 t€ | -47 t€ |
| Equity ratio | 97,5 % | 91,6 % |
| Quick ratio | 13,60 | 3,00 |
| Current ratio | 13,60 | 3,00 |
| Debt to revenue | 3,1 % | 10,7 % |
| Return on equity | 17,7 % | 39,0 % |
| Balance sheet total | 425 t€ | 405 t€ |
| Equity | 414 t€ | 371 t€ |
| Cash and bank | 121 t€ | 79 t€ |
Balance sheet
Balance sheet totalEquityCash
Income statement and balance sheet
Income statement
| 30.11.2025 | 30.11.2024 | |
|---|---|---|
| Turnover | 340 t€ | 318 t€ |
| Raw materials and services | 72 t€ | 67 t€ |
| Personnel expenses | 84 t€ | 47 t€ |
| Depreciations and reductions in value | 1 498 € | 1 998 € |
| Other operating expenses | 29 t€ | 28 t€ |
| Operating profit (loss) | 153 t€ | 174 t€ |
| Financial income and expenses + (-) | 46 t€ | -6 807 € |
| Profit (loss) before appropriations and taxes | 106 t€ | 181 t€ |
| Income taxes | 33 t€ | 37 t€ |
| Profit (loss) for the financial year | 74 t€ | 145 t€ |
Balance sheet
| 30.11.2025 | 30.11.2024 | |
|---|---|---|
| Non-current assets | 282 t€ | 303 t€ |
| Receivables | 22 t€ | 23 t€ |
| Cash in hand and at banks | 121 t€ | 79 t€ |
| Current assets | 143 t€ | 102 t€ |
| Assets | 425 t€ | 405 t€ |
| Share capital or other similar capital | 2 500 € | 2 500 € |
| Capital and reserves | 414 t€ | 371 t€ |
| Short-term liabilities | 11 t€ | 34 t€ |
| Liabilities | 11 t€ | 34 t€ |
All financial statement items (42)
| 30.11.2025 | 30.11.2024 | |
|---|---|---|
| Turnover | 340 t€ | 318 t€ |
| Raw materials and services | 72 t€ | 67 t€ |
| Personnel expenses | 84 t€ | 47 t€ |
| Depreciations and reductions in value | 1 498 € | 1 998 € |
| Other operating expenses | 29 t€ | 28 t€ |
| Operating profit (loss) | 153 t€ | 174 t€ |
| Financial income and expenses + (-) | 46 t€ | -6 807 € |
| Profit (loss) before appropriations and taxes | 106 t€ | 181 t€ |
| Income taxes | 33 t€ | 37 t€ |
| Profit (loss) for the financial year | 74 t€ | 145 t€ |
| Non-current assets | 282 t€ | 303 t€ |
| Receivables | 22 t€ | 23 t€ |
| Cash in hand and at banks | 121 t€ | 79 t€ |
| Current assets | 143 t€ | 102 t€ |
| Assets | 425 t€ | 405 t€ |
| Share capital or other similar capital | 2 500 € | 2 500 € |
| Capital and reserves | 414 t€ | 371 t€ |
| Short-term liabilities | 11 t€ | 34 t€ |
| Liabilities | 11 t€ | 34 t€ |
| Profit (loss) for the period, equity | 74 t€ | 145 t€ |
| Machinery and equipment | 4 495 € | 5 993 € |
| Impairment on investments for non-current assets | 56 t€ | -451 € |
| Other shares and similar rights of ownership | 277 t€ | 297 t€ |
| Pension expenses | 7 838 € | 4 081 € |
| Short-term accounts payable | 2 063 € | 3 787 € |
| Short-term prepayments and accrued income | 2 554 € | 1 865 € |
| Liabilities | 425 t€ | 405 t€ |
| Short-term accrued expenses and deferred income | 1 948 € | 18 t€ |
| Short-term sales receivables | 14 t€ | 12 t€ |
| Interest expenses and other financial expenses for non-Group companies | 308 € | 1 492 € |
| Other current liabilities | 6 511 € | 12 t€ |
| Short-term receivables | 22 t€ | 23 t€ |
| Other short-term receivables | 6 093 € | 8 415 € |
| Income from other investments under non-current assets, from other companies | 9 453 € | 7 816 € |
| Retained earnings | 338 t€ | 224 t€ |
| Investments | 277 t€ | 297 t€ |
| Depreciations according to plan | 1 498 € | 1 998 € |
| Tangible assets | 4 495 € | 5 993 € |
| Services purchased | 72 t€ | 67 t€ |
| Other interest and financial income from non-group companies | 144 € | 31 € |
| Other social security expenses | 1 474 € | 564 € |
| Wages and salaries | 75 t€ | 42 t€ |
From financial statements filed digitally (XBRL) with the Finnish Patent and Registration Office; ratios calculated from them. Equity ratio = (equity + accumulated appropriations) / (balance sheet total − advances received).
Taxes
Measured by taxable income, Höglund Medical Oy is in the top quarter of the industry class medical specialists activities (2077 companies with taxable income; median 81 t€, 2,2 times the median).
Taxable income is the profit as calculated for taxation, not revenue. Public data from the Finnish Tax Administration; figures for 2025 are published in November 2026.